The pharmacological profiles of
1-adrenoceptors for ketanserin, prazosin, silodosin, and BMY 7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4,5]decane-7,9-dione dihydrochloride) were examined under different assay conditions. Among the tested antagonists and
1-adrenoceptors subtypes, ketanserin showed significantly lower affinity for the
1B-adrenoceptor subtype in intact tissue sampled from the rat tail artery, thoracic aorta, and cerebral cortex (functional p
KB and binding p
Ki were approximately 6), than in cerebral cortex membrane preparations or whole cell and membrane preparations of
1B-adrenoceptor transfected
Human Embryonic Kidney 293T (HEK 293T) cells (p
Ki was approximately 8). In these tissues and cells, however, ketanserin showed a similar affinity (p
Ki = approximately 8) for
1A- and
1D-adrenoceptors even though the assays were conducted under different conditions. In contrast, the affinities of
1A-,
1B-, and
1D-adrenoceptors for prazosin, silodosin, and BMY 7378 did not significantly change under different assay conditions and in different tissues. The present study reveals that the pharmacological profiles of native
1B-adrenoceptors for ketanserin is strongly influenced by the assay conditions and suggest that antagonist affinity is not necessarily constant.